314 filings
Page 4 of 16
8-K
86nhricmn7vsh8hjm
21 Sep 21
CytoDyn’s Chairman, CMO, and Head of Business Development Dr. Scott A. Kelly to Present at the World Antiviral Congress 2021
9:29am
8-K
ddl63qcf95p53yk3n0
20 Sep 21
CytoDyn Announces Resolution of Federal Litigation with Rosenbaum/Patterson Activist Group
4:01pm
8-K
vv8uzh
10 Sep 21
CytoDyn Announces Treatment of the First Patient in its Pivotal Phase 3 COVID-19 Trial in Brazil for Patients with Severe Symptoms
4:02pm
8-K
a0g03tshww5 uqk8qzl
7 Sep 21
Entry into a Material Definitive Agreement
5:07pm
8-K
t16hsj ly
2 Sep 21
CytoDyn Highlights Court Ordering Rosenbaum/Patterson Group To Comply With The Federal Securities Laws
9:51pm
8-K
f7mt52prj
25 Aug 21
Other Events
8:11am
8-K
84ch7957b 77ojzq
19 Aug 21
Other Events
8:10am
8-K
hlyf7yfy1h ej
16 Aug 21
CytoDyn Receives FDA Guidance for its HIV BLA Dose Justification Report
5:27pm
8-K
8ghjiknk ntvv
10 Aug 21
Departure of Directors or Certain Officers
5:26pm
8-K
bws3r
5 Aug 21
Other Events
4:10pm
8-K
cgs7hdxu qp9
5 Aug 21
Other Events
4:09pm
8-K
vy1paeranwaho
2 Aug 21
Other Events
7:16am
8-K
yqenh
30 Jul 21
Other Events
4:01pm
8-K
9h7rlpbvy0fw65dctjb
22 Jul 21
Regulation FD Disclosure
5:25pm
8-K
h7jh6wgujn26m0u2kg36
9 Jul 21
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
5:12pm
8-K
1gh 3g30o0
6 Jul 21
Departure of Directors or Certain Officers
4:31pm
8-K
g0pw7p 6g
21 Jun 21
Regulation FD Disclosure
5:23pm
8-K
yymkpbrhcyoff3fyxhbm
15 Jun 21
Termination of a Material Definitive Agreement
5:00pm
8-K
6c1q2jp g4y6be
4 Jun 21
Unregistered Sales of Equity Securities
5:20pm
8-K
klsa12hq
20 May 21
Departure of Directors or Certain Officers
5:18pm